These may include cancer types (e.g., ccRCC vs. non-ccRCC kidney cancer or bladder vs. kidney cancer), species (mouse vs. human), or experimental conditions (e.g., hypoxia, glycolysis, or dual knockdown of GPD1 and GPD1L). The gene discussed is GPD1L; the disease is cancer.